# Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate

> **NCT00331747** · NA · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 20 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Glatiramer acetate

## Key facts

- **NCT ID:** NCT00331747
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331747, "Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00331747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*